Corporate Compliance

Johnson & Johnson kickback case is back on

Compliance Monitor, August 19, 2009

A federal appeals court revived the kickback portion of the case against Johnson & Johnson, according to an article in the Boston Globe. The portion of the case will be heard in the U.S. District Court Boston—the same court that originally dismissed the case.

Two former Johnson & Johnson sales people filed a whistleblower alleging that the company’s Ortho Biotech Products division paid doctors, in the form of free Procrit, honoraria, and other monetary inducements, to prescribe Procrit. 

According to the article, Procrit is among Johnson & Johnson’s most lucrative products, bringing in approximately $2.5 billion last year.

Most Popular